昭衍新药:H股公告:致本公司非登记股东通知信函及申请表格

JOINN Laboratories (China) Co., Ltd.
北京昭衍新藥研究中心股份有限公司
(A joint stock company incorporated in the People’s Republic of China with limited liability)
（於中華人民共和國註冊成立的股份有限公司）
（Stock Code 股份代號：6127）
NOTIFICATION LETTER 通知信函
29 April 2025
Dear Non-Registered Shareholders,
JOINN Laboratories (China) Co., Ltd. (the “Company”)
– Notice of publication of 2024 Annual Report (the “Current Corporate Communication”)
The English and Chinese versions of the Company’s Current Corporate Communications are available on the Company’s website at www.joinnlabs.com and the website of The Stock
Exchange of Hong Kong Limited (the “Stock Exchange”) at www.hkexnews.hk respectively (the “Website Version”). The Company strongly recommends you to access the Website
Version of Current Corporate Communication.
If you have difficulty in receiving email notification or gaining access to the Website Version of the Corporate Communications and would like to receive the Current Corporate
Communication and all future Corporate Communications in printed form, please complete, sign the enclosed Request Form and return it to the Company’s H share registrar in Hong
Kong, Tricor Investor Services Limited (“H Share Registrar”) at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong by post using the provided prepaid mailing label (no
stamp is needed if posted in Hong Kong) or by email to is-ecom@vistra.com. The Company will promptly upon your request send the Current Corporate Communication to you in
printed form free of charge.
As a non-registered shareholder, if you wish to receive Corporate Communications of the Company in electronic form, you should liaise with your bank(s), broker(s),
custodian(s), nominee(s) or HKSCC Nominees Limited through which your shares in the Company are held (collectively, the “Intermediaries”) and provide your email
address to your Intermediaries. Please contact your Intermediaries for the detailed procedure. If the Company does not receive your functional email address from the
Intermediaries, until such time that the functional email address is provided to the Intermediaries, you will be unable to receive any notices of publication of the Website
Version of Corporate Communications (“Notice of Publication”) by email; and the Company would only be able to send you the Notice of Publication in printed form.
Should you have any queries relating to this notification, please call the H Share Registrar’s telephone hotline at (852) 2980 1333 during business hours from 9:00 a.m. to 6:00 p.m.,
Monday to Friday (excluding public holidays).
By Order of the Board
JOINN Laboratories (China) Co., Ltd.
Feng Yuxia
Chairperson
Notes: Non-Registered Holdermeanssuch person orcompany whose sharesare held in The Central Clearing and Settlement System (CCASS) and who hasnotified the Company
from time to time through Hong Kong Securities Clearing Company Limited that such person or company wishes to receive Corporate Communications of the Company.
Corporate Communicationsinclude any document(s) issued orto be issued by the Company forthe information oraction of holdersof any of its securitiesor the investing
public, including but not limited to (a) the directors’ report and its annual accounts together with a copy of the auditors’ report and, where applicable, its summary
financial report; (b) the interim report and, where applicable, its summary interim report; (c) a notice of meeting; (d) a listing document; and (e) a circular.
各位非登記股東：
北京昭衍新藥研究中心股份有限公司（「本公司」）
– 2024年度報告（「本次公司通訊」）之登載通知
本公司的本次公司通訊之中、英文版本已分別上載於本公司網站(www.joinnlabs.com)及香港聯合交易所有限公司（「聯交所」）之網站(www.hkexnews.hk) （「網站版本」）。本公司建議 閣下閱覽本公司本次公司通訊的網站版本。
如 閣下因任何理由無法以電子郵件方式收取或閱覽公司通訊的網站版本，及欲索取本次及日後公司通訊的印刷本，請填妥及簽署隨附之申請表格，並以已預付郵費的郵寄標籤寄回本公司之H股證券登記處（「H股證券登記處」）卓佳證券登記有限公司（地址為香港夏慤道16號遠東金融中心17樓）（如在香港投寄毋須貼上郵票），或電郵至 is-ecom@vistra.com。本公司會因應 閣下之要求立即寄上本次公司通訊的印刷本，費用全免。
作為非登記股東，如 閣下欲以電子方式收取本公司的公司通訊， 閣下應聯絡代 閣下持有股份的銀行、經紀人、託管人、代理人或香港中央結算（代理人）有限
公司（統稱「中介機構」），並向 閣下的中介機構提供 閣下的電子郵件地址。請聯絡 閣下的中介機構以了解詳細程序。如果本公司沒有從中介機構收到 閣下
的有效電子郵件地址，直至中介機構收到 閣下有效的電子郵件地址前，本公司